Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The Polish Medical Association in Chicago effectively supported the Polish community during COVID-19.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

COVID-19 vaccination may lower vitamin D levels and cause hair loss.

COVID-19 can increase the risk of hair loss, especially in people over 40.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

Recent research on androgenetic alopecia focuses on optimizing treatments, with promising new therapies emerging.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

COVID-19 can harm male fertility by reducing sperm stem cells and damaging testicular function.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

Genetic differences affect COVID-19 severity and treatment development.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Working in non-Covid-19 wards and night shifts is linked to higher infection rates among Italian nurses.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.